Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Advanced Solid Tumors × avdoralimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumors 1

Interventions

Injections 19 Carboplatin 15 Docetaxel 13 Paclitaxel 9 Bevacizumab 9 pembrolizumab 8 Cisplatin 7 durvalumab 6 Fluorouracil 6 trifluridine tipiracil drug combination 5 tislelizumab 5 linifanib 5 Leucovorin 5 talazoparib 4 olaparib 4 Pemetrexed 4 Nivolumab 4 Itraconazole 4 Irinotecan 4 zimberelimab 3 sintilimab 3 depatuxizumab 3 atezolizumab 3 ST 1481 3 Rifampin 3 Oxaliplatin 3 Gemcitabine 3 Capecitabine 3 130-nm albumin-bound paclitaxel 3 tremelimumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03665129 2022-01-27

STELLAR-001

Innate Pharma

Phase 1 Terminated

Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡